UPDATE : Monday, October 14, 2019
‘2017 Korea Bioplus’ diagnoses global biotechnology issues by Lee Han-soo 2017-10-23 14:38
Celltrion stock’s short sale causes controversy over trading rules by Lee Han-soo 2017-10-19 18:49
ViroMed eyes global market entry with ‘revolutionary’ gene therapy by Marian Chu 2017-10-19 17:28
Will induced pluripotent stem cells avoid ethical issues? by Nam Doo-hyun 2017-10-17 15:25
TissueGene promotes cell gene therapy Invossa ahead of IPO by Lee Hye-seon 2017-10-17 14:32
Gemvax&Kael present clinical results of prostatic hyperplasia treatment by Lee Han-soo 2017-10-16 16:09
Stem cell treatment for diabetes nears by Nam Doo-hyun 2017-10-13 15:47
Samsung BioLogics’ 2nd factory gets FDA approval by Lee Han-soo 2017-10-12 15:31
Celltrion rises high in Korean stock market by Nam Doo-hyun 2017-10-11 16:11
Samsung Bioepis teams up with Yuhan for biosimilars by Lee Hye-seon 2017-10-11 14:25
Patents on cancer biomarker kit increase at fast pace by Lee Han-soo 2017-10-10 17:44
CJ Healthcare, YL Biologics signs technology transfer agreement by Lee Han-soo 2017-09-28 15:01
LegoChem, Geom Therapeutics signs technology transfer accord by Lee Han-soo 2017-09-27 17:52
Aprogen’s rheumatoid arthritis biosimilar wins sales approval in Japan by Lee Han-soo 2017-09-27 17:45
Celltrion will use Oracle Health platform to streamline processes by Marian Chu 2017-09-27 10:47
Can Celltrion, Samsung make stable earnings with biosimilar? by Nam Doo-hyun 2017-09-26 17:31
Medifron aims high through R&D by Lee Han-soo 2017-09-25 16:19
Korea lags far behind in biomedical R&D: report by Nam Doo-hyun 2017-09-21 16:14
Biosimilar prescriptions fall by the wayside in Korea by Marian Chu 2017-09-21 14:56
Samsung Bioepis gets additional approval for its biosimilar by Lee Hye-seon 2017-09-21 12:03
Back to Top